Federal Circuit Affirms Section 101 Rejection of Pro Se Applicant’s Bartering Method Claims

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today in In re Wenkman affirming a Patent Trial and Appeal Board (PTAB) decision that upheld the rejection of all pending claims in a pro se applicant’s patent application directed to a computer-implemented method for bartering groceries and other goods for silver and gold. The CAFC agreed with the Board that the claims are directed to an abstract idea and lack an inventive concept under 35 U.S.C. Section 101.

C4IP Urges Treasury to Reconsider Proposed Rule to Extend COINS Act Investment Restrictions to Biotech

The Council for Innovation Promotion (C4IP) issued a statement Tuesday expressing concern about a rule recently proposed by the U.S. Department of the Treasury to enact the Comprehensive Outbound Investment National Security (COINS) Act, which was itself enacted as part of the Fiscal Year 2026 National Defense Authorization Act.

Executable Knowledge Artifacts and the Law: The Problem and a Framework

For most of professional history, experience could not be separated from the professional who acquired it. Forms, manuals, and software captured portions of professional judgment, but the judgment itself remained human. That practical limitation preserved two distinctions the law depends on: the distinction between an employer’s property and an employee’s knowledge and skill, and the distinction between one client’s confidences and the next client’s matter. However, modern artificial intelligence (AI) removes this limitation.

Rights Holders of Elvis Compositions File Suit Against Anthropic Over AI Training and Lyrics Output

Several owners of Elvis Presley compositions filed a lawsuit against Anthropic on October 23 in the U.S. District Court for the Northern District of California, alleging that the company copied copyrighted lyrics without authorization to train its Claude large language models (LLMs) and that Claude generated infringing versions of the songs. The complaint asserted claims for direct copyright infringement, circumvention of technological protection measures under Section 1201 of Title 17, and removal or alteration of copyright management information (CMI) under Section 1202.

USPTO 101: Understanding the Risks of Subject Matter Eligibility Declarations | IPWatchdog Unleashed

The USPTO deserves some credit for recognizing that applicants may at times need an opportunity to explain technical improvements that examiners have failed to appreciate, but there is real risk associated with filing a SMED that should cause practitioners to pause rather than race forward without serious consideration. And despite some difference of opinion, we all agreed on an essential point: Filing a SMED should not be the first line of defense against an eligibility rejection; it should should be treated as a last resort. Filing a SMED requires serious consideration of the advantages, disadvantages, and alternatives. Examiner interviews, arguments grounded in the existing specification, appropriate claim amendments, and appeals all deserve careful consideration before ever adding sworn statements to the prosecution history. The question must be whether the declaration supplies something genuinely necessary to advance the case, and even then must be intentionally specific and narrow.

Inventor Advocacy Groups File Amici Briefs Supporting Centripetal’s Claim Construction Challenge at SCOTUS

Last week, the entrepreneur advocacy organization Alliance for U.S. Startups and Inventors for Jobs (USIJ) filed an amicus brief in support of the petition for writ of certiorari before the U.S. Supreme Court filed by patent owner Centripetal Networks challenging late changes to claim construction wrought by the district court without notice or opportunity to be heard in its patent infringement case against Cisco Systems. The USIJ’s filing follows one week after inventor advocacy group US Inventor filed its own amicus brief in support of Centripetal’s petition, arguing that a modest remedy to the deprivation of Centripetal’s due process rights would improve fairness for both patent owners and accused infringers alike.

U.S. Chamber Index Finds 8 of 12 Sampled Economies Score Below 50% in Benchmark of Trade in Unsafe Medicines

The U.S. Chamber of Commerce’s Global Innovation Policy Center released the first edition of its Trade in Unsafe Medicines Index today, a report prepared with Pugatch Consilium that benchmarks 12 economies on their propensity to contribute to trade in unsafe and illicit medicines and their ability to deter it. Eight of the 12 economies scored below 50%, and the overall mean score was 43.03%.

Subscribe to IPWatchdog

This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.

Get Email Updates